SURMODICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.55 USD | +3.66% |
|
+32.02% | -4.95% |
| 02/05 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
| 01/05 | Top Midday Gainers | MT |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 617.1 | 531.1 | 771.3 | 425.8 | 453.6 | 474.5 | - | - |
| Enterprise Value (EV) 1 | 617.1 | 531.1 | 771.3 | 425.8 | 453.6 | 474.5 | 474.5 | 474.5 |
| P/E ratio | 83.2 x | 486 x | 185 x | -15.5 x | -292 x | -35.3 x | 86.4 x | 41.1 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.17 x | 5.6 x | 7.34 x | 4.26 x | 3.42 x | 3.86 x | 3.45 x | 3.08 x |
| EV / Revenue | 6.17 x | 5.6 x | 7.34 x | 4.26 x | 3.42 x | 3.86 x | 3.45 x | 3.08 x |
| EV / EBITDA | 43.7 x | 92.1 x | 64.2 x | -33.1 x | 32.7 x | 76.5 x | 59.3 x | 48.9 x |
| EV / FCF | 302 x | 51.4 x | 76.3 x | -20.7 x | 59.7 x | -21 x | 28.4 x | 17.8 x |
| FCF Yield | 0.33% | 1.95% | 1.31% | -4.84% | 1.67% | -4.76% | 3.52% | 5.63% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 13,491 | 13,650 | 13,872 | 14,005 | 14,134 | 14,236 | - | - |
| Reference price 2 | 45.74 | 38.91 | 55.60 | 30.40 | 32.09 | 34.55 | 34.55 | 34.55 |
| Announcement Date | 31/10/19 | 04/11/20 | 10/11/21 | 09/11/22 | 08/11/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 100.1 | 94.86 | 105.1 | 99.95 | 132.6 | 122.9 | 137.5 | 154.2 |
| EBITDA 1 | 14.13 | 5.765 | 12.02 | -12.85 | 13.87 | 6.2 | 8 | 9.7 |
| EBIT 1 | 6.469 | -1.251 | 6.703 | -22.1 | 5.603 | -9.07 | 9.945 | - |
| Operating Margin | 6.46% | -1.32% | 6.38% | -22.11% | 4.23% | -7.38% | 7.23% | - |
| Earnings before Tax (EBT) 1 | 7.558 | -1.454 | 6.346 | -22.49 | 2.487 | -12.07 | 10.26 | - |
| Net income 1 | 7.592 | 1.123 | 4.237 | -27.27 | -1.536 | -10.71 | 10.16 | - |
| Net margin | 7.59% | 1.18% | 4.03% | -27.29% | -1.16% | -8.71% | 7.39% | - |
| EPS 2 | 0.5500 | 0.0800 | 0.3000 | -1.960 | -0.1100 | -0.9775 | 0.4000 | 0.8400 |
| Free Cash Flow 1 | 2.04 | 10.34 | 10.11 | -20.59 | 7.596 | -22.6 | 16.69 | 26.73 |
| FCF margin | 2.04% | 10.9% | 9.62% | -20.6% | 5.73% | -18.39% | 12.14% | 17.33% |
| FCF Conversion (EBITDA) | 14.44% | 179.34% | 84.1% | - | 54.75% | - | 208.66% | 275.53% |
| FCF Conversion (Net income) | 26.87% | 920.66% | 238.61% | - | - | - | 164.26% | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 31/10/19 | 04/11/20 | 10/11/21 | 09/11/22 | 08/11/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 23.97 | 23 | 26.11 | 24.85 | 25.99 | 24.93 | 27.2 | 52.48 | 27.97 | 30.55 | 31.96 | 29.95 | 30.5 | 33.2 | 34.99 |
| EBITDA 1 | -1.04 | -1.032 | -2.578 | -4.852 | -4.39 | -5.232 | -3.284 | 23.5 | -0.283 | 1.966 | 4.809 | - | - | - | - |
| EBIT 1 | -0.489 | -3.441 | -4.9 | -7.143 | -6.613 | -7.229 | -5.301 | 21.41 | -2.45 | -0.322 | 0.659 | -4.662 | -4.726 | - | 2.3 |
| Operating Margin | -2.04% | -14.96% | -18.77% | -28.74% | -25.45% | -28.99% | -19.49% | 40.8% | -8.76% | -1.05% | 2.06% | -15.57% | -15.5% | - | 6.57% |
| Earnings before Tax (EBT) 1 | -0.562 | -3.518 | -5.002 | -7.181 | -6.792 | -8.008 | -7.365 | 20.65 | -2.789 | -0.724 | 0.166 | -5.712 | -5.776 | - | - |
| Net income 1 | -0.289 | -2.812 | -4.083 | -5.651 | -14.73 | -7.843 | -7.733 | 7.346 | 6.694 | -0.786 | 0.247 | -5.062 | -5.126 | - | - |
| Net margin | -1.21% | -12.22% | -15.64% | -22.74% | -56.67% | -31.46% | -28.43% | 14% | 23.93% | -2.57% | 0.77% | -16.9% | -16.81% | - | - |
| EPS 2 | -0.0200 | -0.2000 | -0.2900 | -0.4100 | -1.060 | -0.5600 | -0.5500 | 0.5200 | 0.4700 | -0.0600 | 0.0200 | -0.3725 | -0.3700 | -0.1200 | -0.0200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/11/21 | 03/02/22 | 27/04/22 | 27/07/22 | 09/11/22 | 06/02/23 | 26/04/23 | 02/08/23 | 08/11/23 | 01/02/24 | 01/05/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 2.04 | 10.3 | 10.1 | -20.6 | 7.6 | -22.6 | 16.7 | 26.7 |
| ROE (net income / shareholders' equity) | - | 0.89% | 3.13% | -22% | - | -9.1% | 7.5% | - |
| ROA (Net income/ Total Assets) | - | - | - | -15.5% | - | -11.7% | 5.2% | - |
| Assets 1 | - | - | - | 176.5 | - | 91.52 | 195.4 | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 6 | 3.67 | 5.28 | 3.37 | 2.92 | 4.74 | 4.75 | 6 |
| Capex / Sales | 5.99% | 3.87% | 5.02% | 3.37% | 2.2% | 3.86% | 3.45% | 3.89% |
| Announcement Date | 31/10/19 | 04/11/20 | 10/11/21 | 09/11/22 | 08/11/23 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.55
USD
Average target price
58.25
USD
Spread / Average Target
+68.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.95% | 474M | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 67.52B | |
| +2.06% | 50.06B | |
| +9.43% | 45.67B | |
| +3.40% | 41B | |
| +3.04% | 26.73B | |
| +4.64% | 26.47B | |
| +15.23% | 25.05B |
- Stock Market
- Equities
- SRDX Stock
- Financials Surmodics, Inc.
